| Name | Title | Contact Details |
|---|
Preco, LLC is a premier provider of solutions for material processing needs. We are a leading designer and manufacturer of high-speed and high-accuracy automated processing systems. In addition, Preco is a skilled laser integrator offering cutting, perforating, welding, and other specialized industrial processing applications. With our proprietary die cutting and laser-based manufacturing capabilities, we are one of the largest contract manufacturing service (CMS) providers in North America offering laser cutting, scoring, perforating, welding, cladding, treat heating and die cutting services.
In 2011, KUIU was launched by founder Jason Hairston with the idea of bringing incredible technology and innovation to serious mountain hunters at fair prices. The goal was to fulfill this mission by doing business with uncompromised commitment to quality and consumer transparency. Utilizing a direct to consumer business model, KUIU has brought revolutionary equipment to the hunting industry based off of a technical layering system designed to keep you comfortable and dry in the most extreme hunting conditions. By eliminating the middleman and introducing unmatched technology at unbelievable pricing, KUIU is bringing to life its motto "Innovation Never Rests".
Estiatorio Milos is a renowned restaurant group founded in 1979 by Greek restaurateur Costas Spiliadis in Montreal. It is celebrated for its authentic Greek cuisine, emphasizing high-quality, fresh ingredients. With locations in major cities like New York, Athens, Las Vegas, Miami, London, Los Cabos, and Dubai, Milos offers refined dining experiences that prioritize simplicity and the art of sharing. The restaurant specializes in Mediterranean seafood, featuring fresh fish and shellfish sourced directly from Greek fishermen. Dishes are crafted to highlight natural flavors, often using artisanal ingredients like cold-pressed Koroneiki olive oil and seasonal vegetables. Milos is known for its warm hospitality and communal dining atmosphere, making it a favorite among discerning diners and culinary enthusiasts seeking an authentic taste of Greece.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.